The main objective of the Prinses Beatrix Spierfonds is to cure muscular disease. The aim of the funding round 'Towards therapy' is to fund scientific research that is an important next step towards a targeted therapy for people with a muscle disease.In this funding round, Rick Wansink, theme Nanomedicine, and Frank Walboomers, theme Reconstructive and regenerative medicine, have been awarded a 250.000 EUR grant of the Prinses Beatrix Spierfonds towards the study and elucidation of myotonic dystrophy, in a project entitled: Harmful RNA in myotonic dystrophy.
More information (only available in Dutch): link.
Related news items
A personal touch of Dimitri Diavatopoulos13 December 2018
In order to promote interaction amongst colleagues within RIMLS, we have a ‘personal touch’ series setting employees in the spotlight. A light-hearted manner to learn about the colleagues you know and those you don’t! This week: Dimitri Diavatopoulos.read more